[1] Darryl C. Baptiste, Michael G. Fehlings. Pharmacological approaches to repair the injured spinal cord [J]. J Neurotrauma, 2006, 23(3-4): 318-334.[2] José E. Pereiraa, Luís M. Costaa, António M. Cabrita, et al. Methylprednisolone fails to improve functional and histological outcome following spinal cord injury in rats [J]. Exp Neurol, 2009, 220(1): 71-81.[3] A. Mofidi, A. Bader, S. Pavlica. The use of erythropoietin and its derivatives to treat spinal cord injury [J]. Mini Rev Med Chem, 2011, 11(9): 763-770.[4] 顾兵,王俊,李华南,等. 大剂量甲强龙冲击治疗大鼠脊髓挫伤的形态学研究[J]. 中国药理学通报, 2012, 28(10): 1417-1423.[5] Young-tae Kim, Jon-Michael Caldwell, Ravi V. Bellamkonda. Nanoparticle-mediated local delivery of methylprednisolone after spinal cord injury [J]. Biomaterials, 2009, 30(13): 2582-2590.[6] Alfredo Gorio, Necati Gokmen, Serhat Erbayraktar, et al. Recombinant human erythropoietin counteracts secondary injury and markedly enhances neurological recovery from experimental spinal cord trauma[J]. Proc Natl Acad Sci USA, 2002, 99(14): 9450-9455.[7] Murat Celik, Necati Gökmen, Serhat Erbayraktar, et al. Erythropoietin prevents motor neuron apoptosis and neurologic disability in experimental spinal cord ischemic injury[J]. Proc Natl Acad Sci USA, 2002, 99(4): 2258-2263.[8] Raad Nashmi, Owen T. Jones, Michael G. Fehlings. Abnormal axonal physiology is associated with altered expression and distribution of Kv1.1 and Kv1.2 K+ channels after chronic spinal cord injury [J]. Eur J Neurosci, 2000, 12(2): 491-506.[9] Alberto Pinzon, Alexander Marcillo, Ada Quintana, et al. A re-assessment of minocycline as a neuroprotective agent in a rat spinal cord contusion model [J]. Brain Res, 2008, 1243: 146-151.[10] Holly H Nash, Rosemary C. Borke, Juanita J. Anders. Ensheathing cells and methylprednisolone promote axonal regeneration and functional recovery in the lesioned adult rat spinal cord [J]. J Neurosci, 2002, 22(16): 7111-7120.[11] Costanza Savino, Rosetta Pedotti, Fulvio Baggi, et al. Delayed administration of erythropoietin and its non-erythropoietic derivatives ameliorates chronic murine autoimmune encephalomyelitis [J]. J Neuroimmunol, 2006, 172(1-2): 27-37.[12] Chang Chia-Mao, Lee Ming-Hsueh, Wang Ting-Chung, et al. Brain protection by methylprednisolone in rats with spinal cord injury [J]. Neuroreport, 2009, 20(10): 968-972.[13] Abdurrahman Cetin, Kemal Nas, Hüseyin Büyükbayram, et al. The effects of systemically administered methylprednisolone and recombinant human erythropoietin after acute spinal cord compressive injury in rats[J]. Eur Spine J, 2006, 15(10): 1539-1544.[14] Jin-Moo Lee, Ping Yan, Qingli Xiao, et al. Methylprednisolone protects oligodendrocytes but not neurons after spinal cord injury [J]. J Neurosci, 2008, 28(12): 3141-3149. [15] Kenneth Maiese, Zhao Zhong-chong, Hou Jin-ling, et al. New strategies for Alzheimer's disease and cognitive impairment [J]. Oxid Med Cell Longev, 2009, 2(5): 279-289.[16] Henrich Cheng, Jey-Pei Wu, Shun-Fen Tzeng. Neuroprotection of glial cell line-derived neurotrophic factor in damaged spinal cords following contusive injury [J]. J Neurosci Res, 2002, 69(3): 397-405.[17] 刘曾旭,王向东,余庆,等. 微囊化兔嗅球细胞悬液移植对脊髓损伤大鼠GFAP及NF200表达的影响[J]. 中国临床解剖学杂志, 2009, 27(5): 566-569.[18] 郝彦明,王洪震,徐又佳,等. 促红细胞生成素对星形胶质细胞损伤的保护作用[J]. 山东医药, 2009, 49(30): 4-6. [19] Park Sung-Jin, Oh In-Soo, Kwon Jae-Young, et al. The effect of irradiation and methylprednisolone in spinal cord injured rats [J]. Spine, 2011, 36(6): 434-440.[20] Liu Wei-Lin, Yi-Hsuan Lee, Shih-Ying Tsai, et al. Methylprednisolone inhibits the expression of glial fibrillary acidic protein and chondroitin sulfate proteoglycans in reactivated astrocytes [J]. Glia, 2008, 56(13): 1390-1400. |